First Republic Capital

Month: October 2014

Nuvo Research® Sells PENNSAID® 2% U.S. Rights for US$45 Million to Horizon Pharma

MISSISSAUGA, ON, Oct. 17, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma plc (NASDAQ:HZNP) for a cash payment ofUS$45 million (CDN$50 million) which was

iWallet Appoints Three New Members to Its Board of Directors

SAN DIEGO, CA–(Marketwired – October 08, 2014) –  iWallet Corporation (OTCQB: IWAL), the secure luxury techcessories company, announced it has appointed three new members to its board of directors including Carl Rosen, former COO of Bulova, then international consumer luxury goods company; Charles Ng, VP of sales at NEXT Biometrics and the former North American